New England Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$180K Sell
2,613
-180
-6% -$12.2K 0.06% 292
2014
Q3
$181K Sell
2,793
-120
-4% -$7.6K 0.06% 302
2014
Q2
$181K Buy
2,913
+56
+2% +$3.34K 0.06% 327
2014
Q1
$168K Sell
2,857
-282
-9% -$15.7K 0.06% 290
2013
Q4
$160K Sell
3,139
-383
-11% -$19.2K 0.07% 294
2013
Q3
$177K Buy
3,522
+285
+9% +$14.9K 0.09% 242
2013
Q2
$159K Buy
+3,237
New +$176K 0.11% 210

Other funds holding LLY

New England Securities's LLY Position: Q4 2014 in Review

New England Securities reduced its Eli Lilly (LLY) stake by 6.4% in Q4 2014, selling an estimated $12.2K and leaving 2,613 shares worth $180K. The position accounts for 0.06% of the portfolio, ranked #292.

New England Securities first reported a position in LLY in Q2 2013 and has held it in 7 quarters since. The position peaked at $181K in Q3 2014. 1,129 funds tracked by Wall St. Rank hold LLY as of Q4 2014.

  • New England Securities held 2,613 shares of Eli Lilly worth $180K as of Q4 2014.
  • New England Securities sold 180 Eli Lilly shares in Q4 2014, an estimated $12.2K.
  • Eli Lilly made up 0.06% of New England Securities's portfolio in Q4 2014, its #292 holding.
  • New England Securities first reported a position in Eli Lilly in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Eli Lilly position peaked at $181K in Q3 2014.
  • 1,129 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.